Thought Leadership

Adding to the SEP Toolkit: AI and SEP Analysis

D. Mass.: “Ensnarement” — a Potent but Often Overlooked Defense to the Doctrine of Equivalents — Need Not Be Raised in the Pleadings

Protecting Your Edge: Detecting Trade Secret Risks and Preparing for Litigation

Texas Round-Up: December 2025

5 in ’25: Appellate

5 in ’25: Standard Essential Patents

5 in ’25: Artificial Intelligence

PTAB Reverses § 101 Rejection Under Desjardins Framework 

USPTO Launches SEP Working Group 

Court Declines To Lift 30-Month Stay To Prevent Alleged Unfair Competitive Advantage Between Generics 

UK High Court Clarifies Scope of SPC Waiver Notification Requirements

Lessons From Recent Pharma & Med Device Federal Circuit Decisions